mental health

J&J preps for FDA panel grilling over depression drug

https://pharmaphorum.com/news/janssen-preps-for-fda-panel-grilling-esketamine/

EU regulators review Janssen’s esketamine nasal spray antidepressant

https://pharmaphorum.com/news/eu-regulators-review-janssens-esketamine-nasal-spray-antidepressant/

Roche Diabetes Care partners with digital therapeutics firm Ieso

https://pharmaphorum.com/news/roche-diabetes-care-ieso-digital-health/

J&J files esketamine nasal spray antidepressant in US

https://pharmaphorum.com/news/jj-files-esketamine-nasal-spray-antidepressant-in-us/

Steve Paul reignites xanomeline research as Karuna CEO

https://pharmaphorum.com/news/steve-paul-reignites-xanomeline-research/

Online scheme tackles financial difficulties and mental health

https://pharmaphorum.com/news/online-scheme-tackles-financial-difficulties-and-mental-health/

Theresa May’s NHS funding pledge insufficient – campaigners

https://pharmaphorum.com/news/more-questions-than-answers-after-mays-nhs-cash-pledge/

Mixed phase 3 results from J&J’s esketamine depression drug

https://pharmaphorum.com/news/mixed-phase-3-results-from-jjs-esketamine-depression-drug/

NI digital “hub” aims to improve youngsters’ mental health

https://pharmaphorum.com/news/ni-digital-hub-aims-improve-youngsters-mental-health/

1 2 3 4 5

Close in 10 seconds

Pharmaphorum.com

Search